STEPHENS INC /AR/ - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$234,166
+10.5%
6,130
+4.3%
0.00%0.0%
Q2 2023$211,911
+89.9%
5,875
+101.1%
0.00%
+100.0%
Q1 2023$111,591
-32.3%
2,922
+0.8%
0.00%
-33.3%
Q4 2022$164,953
+43.4%
2,8990.0%0.00%
+50.0%
Q3 2022$115,000
-10.2%
2,8990.0%0.00%
-33.3%
Q2 2022$128,000
+10.3%
2,8990.0%0.00%
+50.0%
Q1 2022$116,000
+13.7%
2,899
+14.6%
0.00%0.0%
Q4 2021$102,000
-1.0%
2,5300.0%0.00%0.0%
Q3 2021$103,000
-10.4%
2,5300.0%0.00%0.0%
Q2 2021$115,000
+9.5%
2,5300.0%0.00%0.0%
Q1 2021$105,000
+356.5%
2,530
+377.4%
0.00%
Q4 2020$23,000
-72.0%
530
-83.1%
0.00%
-100.0%
Q3 2020$82,000
-23.4%
3,133
-21.7%
0.00%0.0%
Q2 2020$107,000
-25.2%
4,000
-63.6%
0.00%
-60.0%
Q1 2017$143,000
+31.2%
11,0000.0%0.01%
+25.0%
Q4 2016$109,000
-18.0%
11,0000.0%0.00%
-33.3%
Q3 2016$133,000
+40.0%
11,0000.0%0.01%
+50.0%
Q2 2016$95,000
-8.7%
11,0000.0%0.00%
-20.0%
Q1 2016$104,000
-45.5%
11,0000.0%0.01%
-50.0%
Q4 2015$191,000
+29.1%
11,0000.0%0.01%
+25.0%
Q3 2015$148,000
-40.3%
11,0000.0%0.01%
-27.3%
Q2 2015$248,000
+58.0%
11,0000.0%0.01%
+57.1%
Q1 2015$157,000
+25.6%
11,000
-15.4%
0.01%
+16.7%
Q4 2014$125,000
+5.9%
13,0000.0%0.01%0.0%
Q3 2014$118,00013,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders